Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 61 AL 75

A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies

Marciani DJ.

J Neurochem. 2016 Jun;137(5):687-700. doi: 10.1111/jnc.13608. Epub 2016 Apr 6.

Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy

Hamel E, Royea J, Ongali B, Tong XK.

Cell Mol Neurobiol. 2016 Mar;36(2):219-32. doi: 10.1007/s10571-015-0285-4. Epub 2016 Mar 18.

Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies

McGuire MJ, Ishii M.

Cell Mol Neurobiol. 2016 Mar;36(2):203-17. doi: 10.1007/s10571-015-0282-7. Epub 2016 Mar 18.

Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease

Saavedra JM.

Cell Mol Neurobiol. 2016 Mar;36(2):259-79. doi: 10.1007/s10571-015-0327-y. Epub 2016 Mar 18.

Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders

Karim S, Kamal MA, Iqbal Z, Ansari SA, Rasool M, Al-Qahtani MH, Damanhouri G, Mirza Z.

CNS Neurol Disord Drug Targets. 2016;15(4):477-88. doi: 10.2174/1871527315666160321105216.

Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?

Talman V, Pascale A, Jäntti M, Amadio M, Tuominen RK.

Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):149-60. doi: 10.1111/bcpt.12581. Epub 2016 Apr 29.

Intracellular Aβ and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models

Ji L, Zhao X, Lu W, Zhang Q, Hua Z.

Curr Alzheimer Res. 2016;13(6):621-30. doi: 10.2174/1567205013666160322142226.

Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Bursavich MG, Harrison BA, Blain JF.

J Med Chem. 2016 Aug 25;59(16):7389-409. doi: 10.1021/acs.jmedchem.5b01960. Epub 2016 Apr 5.

Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors

Evin G.

BioDrugs. 2016 Jun;30(3):173-94. doi: 10.1007/s40259-016-0168-3.

[Research progress in pharmacological effects of Uncaria Hook on Alzheimer disease models]

Liu L, Zhao YH, Zeng CQ, Zeng Y.

Yao Xue Xue Bao. 2016 Apr;51(4):536-42.

Substance P and Alzheimer's Disease: Emerging Novel Roles

Severini C, Petrella C, Calissano P.

Curr Alzheimer Res. 2016;13(9):964-72. doi: 10.2174/1567205013666160401114039.

Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients

Gauthier S, Rosa-Neto P, Kass JS.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):615-8. doi: 10.1212/CON.0000000000000306.

Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics

Sala Frigerio C, De Strooper B.

Annu Rev Neurosci. 2016 Jul 8;39:57-79. doi: 10.1146/annurev-neuro-070815-014015. Epub 2016 Apr 4.

Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy

Nabavi SF, Braidy N, Orhan IE, Badiee A, Daglia M, Nabavi SM.

Phytother Res. 2016 Apr;30(4):532-9. doi: 10.1002/ptr.5569. Epub 2016 Jan 11.

sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A.

Int J Biochem Cell Biol. 2016 Jun;75:104-11. doi: 10.1016/j.biocel.2016.04.002. Epub 2016 Apr 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias